1. Frisque RJ, Bream GL, Cannella MT. Human Polyomavirus JC virus genome. J Virol 1984;51:458-469.

2. Tooze, J. DNA Tumor Viruses, 2nd edn. New York: Cold Spring Harbor Laboratory, 1981.

3. Kenney S, Natarajan V, Strika V, Khoury G, Salzman NP. JC virus enhancer-promoter active in human brain cells. Science 1984;226:1337-1339.

4. Martin JD, King DM, Slauch M, Frisque RJ. Differences in regulatory sequences of naturally occurring JC virus variants. J Virol 1985;53:306-311.

5. Khalili K, Feigenbaum L, Khoury G. Evidence for a shift in 5'termini of early viral RNA during the lytic cycle of JC virus. Virology 1987;158:469-472.

6. Chen NN and Khalili K. Transcriptional regulation of human JC polyomavirus promoters by cellular proteins YB-1 and Pura in glial cells. J Virol 1995;69:5843-5848.

7. Chen NN, Chang C-F, Gallia G, Kerr DA, Johnson EM, Krachmarov CP, Barr SM, Frisque RJ, Bollag B, Khalili, K. Cooperative action of cellular proteins YB-1 and Pura with the tumor antigen of the human JC polyomavirus determines their interaction with the viral lytic control element. Proc Natl Acad Sci USA 1995;92:1087-1091.

8. Chang C-F, Chen NN, Muralidharan V, Zoltick P, Johnson EM, Khalili K. Evidence that DNA replication of human neurotropic JC virus DNA in glial cells is regulated by a sequence-specific single-stranded DNA-binding protein, Pura . J Virol 1996;70:4150-4156.

9. Major EO, Ameniya K, Tornatore C, Houff S, Berger J. Pathogenesis and molecular biology of progressive multifocal leukeoencephalopaty, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 1992;5:49-73.

10. Finlay CA, Hinds PW, Levine AJ. The p53 protoonco-gene can act as a suppressor of transformation. Cell 1989;57:1083-1093.

11. Ahmed S, Rappaport J, Tada H, Kerr D, Khalili K. A nuclear protein derived from brain cells stimulates transcription of the human neurotropic virus promoter, JCVE, in vitro. J Biol Chem 1990a;265:13899-13905.

12. Ahmed S, Chowdhury M, Khalili K. Regulation of the human neurotropic virus promoter, JCVE: identification of a novel activator domain located upstream from the 98-bp enhancer region. Nucl Acids Res 1990b; 18:7417-7423.

13. Tada H, Lashgari M, Rappaport J, Khalili K. Cell type-specific expression of JC virus early promoter is determined by positive and negative regulation. J. Virol. 1989;63:463-466.

14. Raj GV and Khalili K. Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV. Virology 1995;213:283-291.

15. Walker DL, Padgett BL, ZuRhein GM, Albert AE, Marsh RF. Human papovavirus (JC): induction of brain tumors in hamsters. Science 1973;181:674-676.

16. ZuRhein GM. Studies of JC virus-induced nervous system tumors in the Syrian hamster: a review. In: Sever JL, Madden DM, eds., Polyomaviruses and Human Neurological Disease. New York: Alan R. Liss, 1983;205-221.

17. ZuRhein GM and Varakis J. Perinatal induction of medulloblastomas in Syrian golden hamsters by a human polyoma virus (JC). Natl Cancer Inst Monogr 1979;51:205-208.

18. Houff SA, London WT, ZuRhein GM, Padgett BL, Walker DL, Sever JL New world primates as a model for virus-induced astrocytomas in: Sever JL, Madden DM, eds., Polyomaviruses and Neurologic Disease. New York: Alan R. Liss, 1983;223-226.

19. London WT, Houff SA, Madden DL, Fuccillo DA, Gravell M, Wallen WC, Palmer AE, Sever JL, Padgett BL, Walker DL, ZuRhein GM, Ohashi T. Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus) Science 1978;201:1246-1249.

20. McKeever P, Chronwall B, Houff S, Sever J, Ko-rnblith P, Padgett B, Walker D, London WT. Glial and divergent cells in primate central nervous system tumors induced by JC virus isolated form human progressive multifocal leukoencephalopathy (PML) in: Sever JL, Madden DM, eds., Polyomaviruses and Human Neurological Disease. New York: Alan R. Liss, 1983;239-252.

21. Padgett BL, Walker DL, ZuRhein GM, Varakis J. Differential neurooncogenecity of strains of JC virus, a human polyoma virus, in newborn Syrian hamsters. Cancer Res 1977;37:718-720.

22. Ohsumi S, Motoi M, Ogawa K. Induction of undifferentiated tumors by JC virus in the cerebrum of rats. Acta Pathol 1986;36:815-825.

23. Mandl D, Walker DL, Frisque RJ. Derivation and characterization of POJ cells, transformed human fetal glial cells that retain their permissivity for JC virus. J Virol 1987;61:755-763.

24. Major EO, Mourrain P, Cummins C. JC virus induced owl monkey glioblastoma cells in culture: biolgo-ical properties associated with the viral early gene product. Virology 1984;136:359-367.

25. Major EO, Vacante DA, Traub RG, London WT, Sever JL. Owl monkey astrocytoma cells in culture spontaneously produce infectious JC virus which demonstrates altered biological properties. J Virol 1987;61:1435-1441.

26. Franks R, Rencic A, Gordon J, Zoltick P, Knobler R, Khalili K. Formation of undifferentiated mesenteric tumors in transgenic mice expressing human neurotropic polyomavirus early protein. Oncogene 1996;12:2573-2578.

27. Small JA, Khoury G, Jay G, Howley PM, Scangos GA. Early regions of JC virus and BK virus induce distinct and tissue-specific tumors in transgenic mice. Proc Natl Acad Sei USA 1986;83:8288-8292.

28. Krynska B, Otte J, Franks R, Khalili K, Croul S. Human ubiquitous JCV.CY T-antigen gene induces brain tumors in experimental animals. Oncogene 1999;18:39-46.

29. Gallia G, Gordon J, Khalili K. Tumor pathogenesis of human neurotropic JC virus in the CNS. J Neurovirology 1998;4:175-181

30. Richardson EP. Progressive multifocal leukoen-cephalopathy. New Engl J Med 1961;265:815-823.

31. Davies JA, Hughes JT, Oppenheimer DR. Richardson's Disease. Quart J Med 1973;167:481-501.

32. Castaigne P, Rondot P, Escourolle R, Ribadeau-Dumas J-L, Cathala F, Hauw J-J. Leucoencephalopathie multifocale progressive et "gliomes" multiples. Rev Neurol 1974;130:379-392.

33. GiaRusso MH and Koeppen AH. Atypical progressive multifocal leukoencephalopathy and primary cerebral malignant lymphoma. J Neurol Sei 1978;35:391-398.

34. Tornatore C, Berger JR, Houff SA, Curfman B, Meyers K, Winfield D, Major EO. Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Ann Neurol 1992;31:454-462.

35. Vago L, Cinque P, Sala E, Nebuloni M, Caldarelli R, Racca S, Ferrante P, Trabattoni GR, Costanzi G. JCV-DNA and BKV DNA in the CNS tissue and CSF of AIDS patients and normal subjects. Study of 41 cases and review of the literature. J Acq Immune Defic Synd Human Retrovirol 1996;12:139-146.

36. Azzi A, De Santis R, Leoncini F, Sterrantino G, Marino N, Mazzotta F, Laszlo D, Fanci R, Bosi A. Human polyomaviruses DNA detection in peripheral blood leukocytes from immunocompetent and immunocompromised individuals. J. Neurovirology 1996;2:411-416.

37. Arthur RR, Dagostin S, Shah KV. Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction. J Clin Microbiol 1989;27:1174-1179.

38. Dörries K, Vogel E, Günther S, Czub S. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 1994;198:59-70.

39. White III FA, Ishaq M, Stoner G, Frisque RJ. JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy. J Virol 1992;66:5726-5734.

40. Boldorini R, Caldarelli-Stefano R, Monga G, Zocchi M, Mediati M, Tosoni A, Ferrante F. PCR detection of JC virus DNA in the brain tissue of a 9 year old child with pleomorphic xanthoastrocytoma. J Neurovirology 1998;4:242-245.

41. Rencic A, Gordon J, Otte J, Curtis M, Kovatich A, Zoltick P, Khalili K, Andrews D. Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytoma. Proc Natl Acad Sci USA 1996;93:7352-7357.

42. Major EO and Traub R. JC virus T protein during productive infection in human fetal brain and kidney cells. Virology 1986;148:221-225.

43. Bollag B, Chuke WF, Frisque, R.J. Hybrid genomes of the polyomaviruses JC virus, BK virus, and simian virus 40: Identification of sequences important for efficient transformation. J Virol 1989;63:863-872.

44. Haggerty S, Walker DL, Frisque RJ. JC virus and simian virus 40 genomes containing heterologous regulatory signals and chimeric early regions: Identification of regions restricting transformation by JC virus. J Virol 1989;63:2180-2190.

45. Dyson N, Buchkovich K, Whyte P, Harlow E. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 1989;58:249-255.

46. Dyson N, Bernards R, Friend SH, Gooding LR, Has-sell JA, Major EO, Pipas JM, Van Dyke T, Harlow E. Large T antigens of many polyoma viruses are able to form complexes with the retinoblastoma protein. J Virol 1990;64:1353-1356.

47. Chellapan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the RB protein. Cell 1991;65:1053-1061.

48. Helin K, Harlow E, Fattaey AR. Inhibition of E2F-1 transactivation by direct binding of the reinoblastoma protein. Mol Cell Biol 1993;13:6501-6508.

49. Hiebert SW, Chellapan SP, Horowitz JM, Nevins JR. The interaction of pRb with E2F inhibits the transcriptional activity of E2F. Genes Dev 1992;6:177-185.

50. Weintraub SJ, Pater CA, Dean DC. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 1992;358:259-261.

51. Raychaudhuri P, Rooney R, Nevins JR. Identification of an ElA-inducible cellular factor that interacts with regulatory sequences within the adenovirus E4 promoter. EMBO J 1987;6:4073-4081.

52. Famham PJ, Slansky JE, Kollmar R. The role of E2F in the mammalian cell cycle. Biochima and Biphysica Acta 1993;1155:125-131.

53. Nevins JR. Cell cycle targets of the DNA tumor viruses. Curr Op Genet Dev 1994;4:130-134.

54. Neuman E, Flemington EK, Sellers WR, Kaelin WG. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol Cell Biol 1994;14:6607-6615.

55. Slansky JE, Li Y, Kaelin WG, Farnham PJ A protein synthesis-dependent increase in E2F-1 mRNA

correlates with growth regulation of the dihydrofolate reductase promoter. Mol Cell Biol 1993; 13:16101618.

56. LaThangue NB. DP and E2F proteins: components of a heterodimeric transcription factor implicated in cell cycle control. Curr Opin Cell Biol 1994;6:443^50.

57. Ivey-Hoyle M, Conroy R, Huber HE, Goodhart PJ, Oliff A, Heimbrook DC. Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol Cell Biol 1993;13:7802-7812.

58. Krek W, Livingston DM, Shirodkar S. Binding to DNA and the retinoblastoma gene product is promoted by complex formation of different E2F family members. Science 1993;262:1557-1560.

59. Lees JA, Saito M, Vidal M, Valentine M, Look T, Harlow E, Dyson N, Helin K. The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol 1993;13:7813-7825.

60. Sardet C, Vidal M, Cobrinik D, Geng Y, Onufryk C, Chen A, Weinberg RA. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci USA 1995;92:2403-2407.

61. Kaelin WG, Krek W, Sellers WR, DeCaprio JA, Ajchenbaum F, Fuchs CS, Chittenden T, Li Y, Farn-ham PJ, Blanar MA, Livingston DM, Flemington EK. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 1992;70:351-364.

62. Li Y, Slansky JE, Myers DJ, Drinkwater NR, Kaelin WG, Farnham PJ. Cloning, chromosomal location, and characterization of mouse E2F1. Mol Cell Biol 1994;14:1861-1869.

63. Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 1992;70:337-350.

64. Girling R, Partridge JF, Bandara LR, Burden N, Totty NF, Hsuan JJ, La Thangue NB. A new component of the transcription factor DRTF1/E2F. Nature 1993;362:83-87.

65. Lee J, Hollenberg SM, Snider L, Turner DL, Lipnick N, Weintraub H. Conversion of xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science 1995;268:836-839.

66. Logan TJ, Jordan KL, Hall DJ. Altered shape and cell cycle characteristics of fibroblasts expressing the E2F1 transcription factor. Mol Cell Biol 1994;5:667-678.

67. Johnson DG, Schwarz JK, Cress WD, Nevins JR. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 1993;365:349-352.

68. Massague J. The transforming growth factor (family. Ann Rev Cell Biol 1990;6:597-641.

69. Roberts AB and Sporn MB. Handbook of Experimental Pharmacology: Peptide Growth Factors and Their Receptors I, VOL. 95.NEW YORK: Springer-Verlag, 1990;419^172.

70. Schwartz JK, Bassing CH, Kovesdi I, Datto M, Blazing M, George S, Wang X-F, Nevins JR. Expression of the E2F1 transcription factor overcomes type (transforming growth factor-mediated growth suppression. Proc Natl Acad Sci USA 1995;92:483-487.

71. Kim T-A, Ravitz M, Wenner C. Transforming growth factor-(regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts. J Cell Phys 1994;160:1-9.

© 2000 Elsevier Science B.V. All rights reserved. Cancer and Autoimmunity Y. Shoenfeld and M. E. Gershwin, editors

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment